Unlocking the Potential of Disulfidptosis: Nanotechnology‐Driven Strategies for Advanced Cancer Therapy
Small · 2025-06 · 21 (23)
DOI: 10.1002/smll.202500880 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 24.04.2025. Verfasst von Wenyao Zhen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore. Hauptthemen laut MEDLINE: Neoplasms, Nanotechnology, Apoptosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: National Medical Research Council, National Research Foundation, National University of Singapore.
Abstract (Originalsprache)
Tumor tissues exhibit elevated oxidative stress, with the cystine‐glutamate transporter x CT solute carrier family 7 member 11 ( x CT/SLC7A11) protecting cancer cells from oxidative damage by facilitating cystine uptake for glutathione synthesis. Disulfidptosis, a newly identified form of programmed cell death (PCD), occurs in cells with high x CT/SLC7A11 expression under glucose‐deprived conditions. Distinct from other PCD pathways, disulfidptosis is characterized by aberrant disulfide bond formation and cellular dysfunction, ultimately resulting in cancer cell death. This novel mechanism offers remarkable therapeutic potential by targeting the inherent oxidative stress vulnerabilities of rapidly growing cancer cells. Advances in nanotechnology enable the development of nanomaterials capable of inducing reactive oxygen species (ROS) generation, disrupting disulfide bonds. In addition, they are capable to deliver therapeutic agents directly to tumors, thereby improving therapeutic precision and minimizing off‐target effects. Moreover, combining disulfidptosis with ROS‐induced immunogenic cell death can remodel the tumor microenvironment and enhance anti‐tumor immunity. This review explores the mechanisms underlying disulfidptosis, its therapeutic potential in cancer treatment, and the synergistic role of nanotechnology in amplifying its effects. Selective induction of disulfidptosis using nanomaterials represents a promising strategy for achieving more effective, selective, and less toxic cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
- Theranostics Centre of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 138667, Singapore.
- Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117575, Singapore.
- Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117575, Singapore.
ORCID-Profile: Xiaoyuan Chen
Förderung
- National Medical Research Council
- National Research Foundation
- National University of Singapore
Zitieren
APA
Zhen, W., Zhao, T., Chen, X., & Zhang, J. (2025). Unlocking the Potential of Disulfidptosis: Nanotechnology‐Driven Strategies for Advanced Cancer Therapy. Small, 21(23). https://doi.org/10.1002/smll.202500880
Vancouver
Zhen W, Zhao T, Chen X, Zhang J. Unlocking the Potential of Disulfidptosis: Nanotechnology‐Driven Strategies for Advanced Cancer Therapy. Small. 2025;21(23). doi:10.1002/smll.202500880
BibTeX
@article{Zhen2025,
author = {Zhen, Wenyao and Zhao, Tianzhi and Chen, Xiaoyuan and Zhang, Jingjing},
title = {Unlocking the Potential of Disulfidptosis: Nanotechnology‐Driven Strategies for Advanced Cancer Therapy},
journal = {Small},
year = {2025},
volume = {21},
number = {23},
doi = {10.1002/smll.202500880}
}
EUVIMED